From Solid-State Control to Predictive Precision: Building a Deployable Ecosystem for Psychedelic Therapeutics
Abstract
Two recent patent applications illustrate how psychedelic drug development is expanding beyond molecules and experiences toward deployable therapeutic systems. One focuses on solid-state optimization of a lysergamide analogue to ensure manufacturability and stability, while the other applies machine-learning-driven neurophysiological biomarkers to predict patient response. Together, they address complementary translational bottlenecks in psychedelic medicine.
Fields of Study & Subjects
Psychedelics and Drug Studies
Treatment of Major Depression
Forensic Toxicology and Drug Analysis
Publication details
- Journal / source
- ACS Medicinal Chemistry Letters
- Volume
- 17
- Issue
- 2
- Pages
- 306–308
- Publication date
- 12 January 2026
- Language
- EN